You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
19 November 2021
New Zealand’s AFT Pharmaceuticals has struck a deal with McPherson’s to “drive growth of its OTC products in Singapore” and reported worldwide sales up by 14% in the six months ended 30 September 2021.
24 September 2021
New Zealand’s AFT Pharmaceuticals has expanded its European business development team as it seeks to overcome the barriers to international business travel associated with the COVID-19 pandemic. In a separate development, the company has gained authorisations for its Maxigesic analgesic in Chile, Pa...
13 September 2021
Sun Pharma has entered the nutrition bar segment in India with its Revital brand, The Bountiful Company has extended Sundown Kids in the US, and AFT Pharmaceuticals is seeking a change to the classification of ibuprofen in New Zealand.
15 July 2021
Bausch Health Companies has extended its Biotrue eyecare brand in the US, Bayer Consumer Health is backing the launch of AleveX with a golf-themed campaign, and AFT Pharmaceuticals has received regulatory approval for Maxigesic Oral Liquid in two countries.
28 May 2021
AFT Pharmaceuticals reported sales up by 7% to NZD113 million (USD81.6 million) in the 12 months ended 31 March 2021. The New Zealand company said the tablet version of its Maxigesic combination painkiller was available in 43 countries at the end of the 12-month period, up from 28 a year earlier.
8 April 2021
New Zealand’s AFT Pharmaceuticals has signed a licensing agreement for its Maxigesic combination painkiller with Polish company Mercapharm. The company has also revised its financial guidance following delays and disruptions related to the COVID-19 pandemic.
13 January 2021
Maxwellia has appointed a finance director, Bayer has recruited a chief transformation and talent officer, and AFT Pharmaceuticals has gained expertise in North America.